(Q44548374)

4 December 2017

title

BEAC or BEAM for high-dose therapy in patients with non-Hodgkin's lymphoma? A single centre analysis on toxicity and efficacy (English)

1 reference

4 December 2017

Jantunen E

1

1 reference

4 December 2017

Kuittinen T

series ordinal

2

1 reference

4 December 2017

Nousiainen T

series ordinal

3

1 reference

4 December 2017

publication date

1 July 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

44

1 reference

4 December 2017

issue

7

1 reference

4 December 2017

page(s)

1151-1158

1 reference

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000083028

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000083028

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000083028

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000083028

Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000083028

Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000083028

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000083028

Current trends in hematopoietic stem cell transplantation in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000083028

BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000083028

Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (>/=60 years) with non-Hodgkin's lymphoma: comparison with patients <60 years treated within the same protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000083028

High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin's lymphoma: results of outpatient treatment in community cancer centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000083028

Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000083028

10.1080/1042819031000083028

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference